Novonesis A/S
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Novonesis A/S
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.
/ 
Frequently asked questions
To buy Novonesis A/S stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Novonesis A/S by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Novonesis A/S is NSIS_B:xcse. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Novonesis A/S has its primary listing on NASDAQ OMX Copenhagen. You can trade Novonesis A/S with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Novonesis A/S is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Novonesis A/S as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Novonesis A/S.